First Command Advisory Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Other funds holding SRNE
First Command Advisory Services's SRNE Position: Q2 2026 in Review
First Command Advisory Services opened a new position in Sorrento Therapeutics, Inc. (SRNE) in Q2 2026: 569 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1353 among its holdings.
5 funds tracked by Wall St. Rank hold SRNE as of Q2 2026.
- First Command Advisory Services held 569 shares of Sorrento Therapeutics, Inc. worth $0 as of Q2 2026.
- Sorrento Therapeutics, Inc. was a new First Command Advisory Services position in Q2 2026.
- Sorrento Therapeutics, Inc. made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #1353 holding.
- 5 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2026.
Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.